Venture
Knopp Biosciences LLC
Latest Form D 2021-01-05- CIK 1497598
- State PA
- Biotechnology
- 7 Form D offerings since 2010-09-03
- Total sold
- $211M
- across 7 offerings
- Rounds
- 7
- Form D offerings since 2010-09-03
- Latest round
- $0K
- 2021-01-05 · 021-385230
- Investors
- 1
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2021-01-05 · $0K
- 2010-09-03$140M021-147270
- 2012-07-09$14.9M021-180850
- 2014-04-14$28M021-215457
- 2019-02-27$14.9M021-333670
- 2020-03-05$1M021-362057
- 2020-07-07$12.6M021-370327
- 2021-01-05$0K021-385230
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($140M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-385230 | First filed2021-01-05 | Latest2021-01-05 | Sought$0K | Sold$0K | Investors1 | Exemptions506(b) |
| 021-370327 | First filed2020-07-07 | Latest2020-10-27 | Sought$26M | Sold$12.6M | Investors24 | Exemptions506(b) |
| 021-362057 | First filed2020-03-05 | Latest2020-03-05 | Sought$3M | Sold$1M | Investors1 | Exemptions506(b) |
| 021-333670 | First filed2019-02-27 | Latest2020-06-19 | Sought$30M | Sold$14.9M | Investors78 | Exemptions506(b) |
| 021-215457 | First filed2014-04-14 | Latest2018-07-24 | Sought$31.3M | Sold$28M | Investors61 | Exemptions506(b) |
| 021-180850 | First filed2012-07-09 | Latest2013-07-18 | Sought$30M | Sold$14.9M | Investors78 | Exemptions506 |
| 021-147270 | First filed2010-09-03 | Latest2010-09-03 | Sought$140M | Sold$140M | Investors90 | Exemptions506 |
Who backs Knopp Biosciences LLC, inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-01-05
| Name | Relationship | Clarification |
|---|---|---|
| Michael E. Bozik | RelationshipExecutive Officer, Director, Promoter | ClarificationLLC Manager |
| Gregory T. Hebrank | RelationshipExecutive Officer, Director, Promoter | ClarificationLLC Manager |
| Thomas V. Petzinger Jr. | RelationshipExecutive Officer, Director, Promoter | ClarificationLLC Manager |
| Jeffrey S. McCormick | RelationshipDirector | ClarificationLLC Manager |
| Benjamin A. Gomez | RelationshipDirector | ClarificationLLC Manager |
| Steven Dworetzky | RelationshipExecutive Officer | Clarification— |
| Calman Prussin | RelationshipExecutive Officer | Clarification— |
| Mark Kreston | RelationshipExecutive Officer | Clarification— |
| James Mather | RelationshipExecutive Officer | Clarification— |
| Stephen E Butts | RelationshipDirector | ClarificationLLC Manager |
| C. David Adair | RelationshipDirector | ClarificationLLC Manager |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Saturn Capital, Inc. | CRD15412 | Broker-dealer— | Offerings3 |
| MIP Global, Inc. | CRD164640 | Broker-dealer— | Offerings1 |
| Stillpoint Capital, LLC | CRD133146 | Broker-dealer— | Offerings1 |
| Pickwick Capital Partners, LLC | CRD130672 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Pennsylvania (PA)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2010-09-03
- Latest filing
- 2021-01-05
Who backs Knopp Biosciences LLC
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗